Literature DB >> 34813298

Irilone, a Red Clover Isoflavone, Combined with Progesterone Enhances PR Signaling through the Estrogen and Glucocorticoid Receptors.

Julia R Austin1, Kailiang Li1, Rocío Rivera Rodríguez1, Daniel D Lantvit1, Brian T Murphy1, Joanna E Burdette1.   

Abstract

Trifolium pratense L. (red clover) is a popular botanical supplement used for women's health. Irilone isolated from red clover previously demonstrated progestogenic potentiation activity. In this study, irilone enhanced progesterone signaling was determined to not occur due to post-translational phosphorylation or by reducing progesterone receptor (PR) protein levels but instead increased PR protein levels in T47D breast cancer cells, which could be blocked by estrogen receptor (ER) antagonists, suggesting an ER dependent effect. Further, irilone increased luciferase activity from a hormone responsive element in a cell line that lacked ER and PR but expressed the glucocorticoid receptor (GR). A siRNA knockdown of GR in Ishikawa PR-B endometrial cancer cells reduced irilone's ability to enhance progesterone signaling. In an ovariectomized CD-1 mouse model, irilone did not induce uterine epithelial cell proliferation. The mechanism of action of irilone gives insight into PR crosstalk with other steroid hormone receptors, which can be important for understanding botanicals that are used for women's health.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34813298      PMCID: PMC9152987          DOI: 10.1021/acs.jnatprod.1c00835

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.803


  42 in total

1.  Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome.

Authors:  C A Lange; T Shen; K B Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  The Flavonoid Apigenin Is a Progesterone Receptor Modulator with In Vivo Activity in the Uterus.

Authors:  Matthew Dean; Julia Austin; Ren Jinhong; Michael E Johnson; Daniel D Lantvit; Joanna E Burdette
Journal:  Horm Cancer       Date:  2018-05-07       Impact factor: 3.869

Review 3.  Progesterone action in breast, uterine, and ovarian cancers.

Authors:  Caroline H Diep; Andrea R Daniel; Laura J Mauro; Todd P Knutson; Carol A Lange
Journal:  J Mol Endocrinol       Date:  2015-01-13       Impact factor: 5.098

4.  Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus.

Authors:  J Ham; A Thomson; M Needham; P Webb; M Parker
Journal:  Nucleic Acids Res       Date:  1988-06-24       Impact factor: 16.971

5.  The red clover isoflavone irilone is largely resistant to degradation by the human gut microbiota.

Authors:  Annett Braune; Ronald Maul; Nils Helge Schebb; Sabine E Kulling; Michael Blaut
Journal:  Mol Nutr Food Res       Date:  2010-07       Impact factor: 5.914

6.  Glucocorticoid- and progesterone-specific effects are determined by differential expression of the respective hormone receptors.

Authors:  U Strähle; M Boshart; G Klock; F Stewart; G Schütz
Journal:  Nature       Date:  1989-06-22       Impact factor: 49.962

Review 7.  Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions.

Authors:  Peter Thomas
Journal:  Front Neuroendocrinol       Date:  2008-02-01       Impact factor: 8.606

Review 8.  Botanicals and Their Bioactive Phytochemicals for Women's Health.

Authors:  Birgit M Dietz; Atieh Hajirahimkhan; Tareisha L Dunlap; Judy L Bolton
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

9.  Baicalein Is a Phytohormone that Signals Through the Progesterone and Glucocorticoid Receptors.

Authors:  Julia R Austin; Brenna J Kirkpatrick; Rocío Rivera Rodríguez; Michael E Johnson; Daniel D Lantvit; Joanna E Burdette
Journal:  Horm Cancer       Date:  2020-03-07       Impact factor: 3.869

Review 10.  Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.

Authors:  J Julie Kim; Takeshi Kurita; Serdar E Bulun
Journal:  Endocr Rev       Date:  2013-01-09       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.